Return on Assets: An indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets. Calculated as: Income from Continuing Operations / Total Assets
Entrada Therapeutics, Inc. (TRDA) had Return on Assets of -10.38% for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
$1.30M |
|
$-39.16M |
|
-- |
|
$1.30M |
|
$43.51M |
|
$-42.21M |
|
$3.14M |
|
$-39.07M |
|
$-39.07M |
|
$-39.16M |
|
$-39.16M |
|
$-39.16M |
|
$-39.16M |
|
$-42.21M |
|
$-41.95M |
|
41.37M |
|
41.37M |
|
$-0.95 |
|
$-0.95 |
|
| Balance Sheet Financials | |
$306.25M |
|
$7.31M |
|
$71.13M |
|
$377.38M |
|
$24.45M |
|
-- |
|
$46.79M |
|
$71.25M |
|
$306.13M |
|
$306.13M |
|
$306.13M |
|
37.59M |
|
| Cash Flow Statement Financials | |
$-128.51M |
|
$116.81M |
|
$0.89M |
|
$105.16M |
|
$94.34M |
|
$-10.82M |
|
$19.61M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
12.53 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-3249.27% |
|
-3249.27% |
|
-- |
|
-3007.86% |
|
-3014.94% |
|
$-129.55M |
|
-- |
|
-- |
|
-- |
|
0.00 |
|
-- |
|
1.10 |
|
81.55 |
|
-12.79% |
|
-12.79% |
|
|
Return on Assets |
-10.38% |
-12.79% |
|
$8.14 |
|
$-3.13 |
|
$-3.11 |
|